Tag: MTC HEA BIO PHA

Announcement of fully underwritten rights issue

OSLO, Norway, June 30, 2025 /PRNewswire/ -- BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription...

Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies

Shasqi is a leader in the translational application of click chemistry, a Nobel Prize winning technology, and the first company to use this technology in...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsMTC HEA BIO PHA

ROYAL CARIBBEAN OFFICIALLY WELCOMES LEGEND OF THE SEAS TO THE REVOLUTIONARY ICON CLASS, BUILT IN COLLABORATION WITH MEYER TURKU

ROYAL CARIBBEAN OFFICIALLY WELCOMES LEGEND OF THE SEAS TO THE REVOLUTIONARY ICON CLASS, BUILT IN COLLABORATION WITH MEYER TURKU

Program Announcement for Annual ASPC Congress on CVD Prevention, July 2026

Tag: MTC HEA BIO PHA

Announcement of fully underwritten rights issue

Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us